2-戊基环己-1-酮 | 32362-97-3

• 分子结构分类: 有机化合物 - 有机氧化合物
• 中文名称: 2-戊基环己-1-酮
• 中文别名: 2-戊基-1-环己酮
• 英文名称: 2-pentylcyclohexanone
• 英文别名: amylcyclohexanone；2-Pentyl-cyclohexanon；2-pentylcyclohexan-1-one
• CAS: 32362-97-3
• 化学式: C₁₁H₂₀O
• 分子量: 168.279
• InChiKey: UXJMXERXJQAWSP-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  3.5
• 重原子数：
  12
• 可旋转键数：
  4
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.91
• 拓扑面积：
  17.1
• 氢给体数：
  0
• 氢受体数：
  1

安全信息

• 海关编码：
  2914299000

反应信息

• 作为反应物：
  描述：

  2-戊基环己-1-酮 在 甲烷磺酸 、 copper(ll) bromide 作用下， 以 乙腈 为溶剂， 生成 2-戊基苯酚
  参考文献：
  名称：

  通过溴化铜（II）介导的氧化作用的α，β-不饱和酮

  摘要：

  据报道，用于实现烯醇乙酸酯的快速Saegusa型氧化的方案。这种新方法依赖于使用溴化铜（II）原位消除α-溴中间体以生成α，β-不饱和酮。开发的方法学应用于包括环己酮在内的多种底物，可以直接转化为相应的苯酚衍生物。作为原理的证明，还开发了一种催化系统，其中使用亚化学计量的CuBr 2成功氧化了未掩蔽的酮。

  DOI：

  10.1016/j.tet.2016.04.011
• 作为产物：
  描述：

  螺[1,3,5,6,7,8-六氢喹唑啉-2,1'-环己烷]-4-酮 在 氢氧化钾 、 硫酸 、 sodium ethanolate 作用下， 以 甲醇 、 乙醇 为溶剂， 生成 2-戊基环己-1-酮
  参考文献：
  名称：

  Bischoff,C.; Herma,H., Journal fur praktische Chemie (Leipzig 1954), 1976, vol. 318, p. 773 - 778

  摘要：

  DOI：

文献信息

• New method for generation of β-oxido carbenoid via ligand exchange reaction of sulfoxides: A versatile procedure for one-carbon homologation of carbonyl compounds
  作者：Tsuyoshi Satoh、Norifumi Itoh、Kaoru Gengyo、Sae Takada、Naoyuki Asakawa、Yumi Yamani、Koji Yamakawa

  DOI：10.1016/s0040-4020(01)89299-1

  日期：1994.1

  one-carbon homologation of carbonyl compounds is described. The method is based on the rearrangement of β-oxido carbenoid which is generated via the ligand exchange reaction of the sulfinyl group of α-chloro β-hydroxy sulfoxide with tert-butyllithium. Addition of the carbanion of aryl 1-chloroalkyl sulfoxides to carbonyl compounds gave the adducts in good yields. The β-oxido carbenoid rearrangement of the

  描述了一种新的羰基化合物一碳同系化方法。该方法基于通过α-氯β-羟基亚砜的亚磺酰基与叔丁基锂的配体交换反应而产生的β-氧化类胡萝卜素的重排。将芳基1-氯烷基亚砜的碳负离子加到羰基化合物上，以高收率得到加合物。加合物的β-氧化类胡萝卜素重排得到具有α-烷基取代基的一碳同系羰基化合物。衍生自羰基化合物的加合物与氯甲基对甲苯基亚砜的类似反应产生了亚甲基插入的程序。还讨论了β-氧化类胡萝卜素重排的立体化学。
• A novel method for generation of carbenoid from α-chloro sulfoxides: A new and versatile procedure for one-carbon homologation of carbonyl compounds to carbonyl compounds having an α-alkyl substituent
  作者：Tsuyoshi Satoh、Norifumi Itoh、Kaoru Gengyo、Koji Yamakawa

  DOI：10.1016/s0040-4039(00)60819-5

  日期：——

  Addition of the carbanion of 1-chloroalkyl p-tolyl sulfoxides to carbonyl compound gave the adducts, which were treated with a base followed by t-butyllithium to afford one-carbon homologated carbonyl compounds having an alkyl group at the α-position, via the β-oxido carbenoids, in moderate to good yields.

  将1-氯烷基对甲苯基亚砜的碳负离子加到羰基化合物上，得到加合物，将其用碱处理，然后用叔丁基锂处理，以得到通过α-位在烷基上具有烷基的一碳均聚羰基化合物。 β-氧化类胡萝卜素，产量中等至良好。
• 5-ALKYL PYRROLIDINE OREXIN RECEPTOR AGONISTS
  申请人：Merck Sharp & Dohme Corp.

  公开号：US20200255403A1

  公开（公告）日：2020-08-13

  The present invention is directed to 5-alkyl pyrrolidine compounds which are agonists of orexin receptors. The present invention is also directed to uses of the compounds described herein in the potential treatment or prevention of neurological and psychiatric disorders and diseases in which orexin receptors are involved. The present invention is also directed to compositions comprising these compounds. The present invention is also directed to uses of these compositions in the potential prevention or treatment of such diseases in which orexin receptors are involved.

  本发明涉及对促进睡眠素受体的激动剂的5-烷基吡咯烷化合物。本发明还涉及所述化合物在潜在的治疗或预防涉及促进睡眠素受体的神经和精神障碍和疾病中的用途。本发明还涉及包含这些化合物的组合物。本发明还涉及这些组合物在潜在的预防或治疗涉及促进睡眠素受体的疾病中的用途。
• [EN] NOVEL SUBSTITUTED 1,2,4-TRIOXANES USEFUL AS ANTIMALARIAL AGENTS AND A PROCESS FOR THE PREPARATION THEREOF<br/>[FR] NOUVEAUX 1,2,4-TRIOXANES SUBSTITUES UTILISES COMME ANTIPALUDIQUES ET PROCEDE DE PREPARATION DE CES ANTIPALUDIQUES
  申请人：COUNCIL SCIENT IND RES

  公开号：WO2003082852A1

  公开（公告）日：2003-10-09

  In the present invention relates to a novel series of antimalarial 1,2,4-trioxanes analogues of general formula (7), wherein R represents cycloalkyl groups selected from the groups consisting of cyclopentyl, cyclohexyl, cycloheptyl and cyclooctyl or aryl groups selected from phenyl, 4-bromophenyl and 4-chlorophenyl, R1 and R2 represent hydrogen, alkyl group selected from methyl, ethyl, propyl and decyl, aryl selected from phenyl or parts of a cyclic systems such as cyclopentane, cyclohexane, substituted cyclohexane, cycloheptane bicyclo(2.2.1)heptane, adamantane and its preparation thereof; several of these novel compounds show promising antimalarial activity against multidrug resistant malaria in mice.

  本发明涉及一种新的抗疟疾1,2,4-三氧杂环己烷类似物的一般式(7)，其中R代表从环戊基、环己基、环庚基和环辛基中选择的环烷基或从苯基、4-溴苯基和4-氯苯基中选择的芳基，R1和R2代表氢、从甲基、乙基、丙基和癸基中选择的烷基，从苯基中选择的芳基或环戊烷、环己烷、取代环己烷、环庚烷、双环[2.2.1]庚烷、金刚烷等环系统的部分；这些新化合物中的一些显示出对小鼠多药耐药疟疾具有很好的抗疟活性。
• [EN] TRIAZA-SPIROPIPERIDINE DERIVATIVES FOR USE AS GLYT-1 INHIBITORS IN THE TREATMENT OF NEUROLOGICAL AND NEUROPSYCHIATRIC DISORDERS<br/>[FR] DERIVES DE TRIAZA-SPIROPIPERIDINE A UTILISER COMME INHIBITEURS DE GLYT-1 DANS LE TRAITEMENT DE TROUBLES NEUROLOGIQUES ET NEUROPSYCHIATRIQUES
  申请人：HOFFMANN LA ROCHE

  公开号：WO2005040166A1

  公开（公告）日：2005-05-06

  The invention relates to compounds of the general formula (I), wherein A-A is -CH2-CH2-, -CH2-CH2-CH2-, -CH2-0- or -0-CH2-; x is hydrogen or hydroxy; R1 is aryl or heteroaryl, unsubstituted or substituted by one or more substituents, selected from the group consisting of lower alkyl, lower alkoxy, halogen or trifluoromethyl; R2 is aryl or heteroaryl, unsubstituted or substituted by one or more substituents, selected from the group consisting of lower alkyl, lower alkoxy, halogen or trifluoromethyl, or is lower alkyl, -(CH2)n-­cycloalkyl, -(CH2)n-CF3, -(CH2)p-0-lower alkyl, -(CH2)1,2-phenyl, optionally substituted by halogen, lower alkyl, lower alkoxy or trifluoromethyl, or is -(CH2)p-NRR', wherein W and R' form together with the N-atom a heterocyclic ring, selected from the group consisting of piperidine, morpholine, thiomorpholine or 1, I-dioxo thiomorpholine; R3, R4 are independently from each other hydrogen, lower alkyl, phenyl or benzyl; R5 is hydrogen, lower alkyl or benzyl; R6 is hydrogen or lower alkyl; n is 0, 1 or 2; and p is 2 or 3; and to pharmaceutically acceptable acid addition salts thereof for the treatment of psychoses, pain, neurodegenerative disfunction in memory and learning, schizophrenia, dementia and other diseases in which cognitive processes are impaired, such as attention deficit disorders or Alzheimer's disease.

  该发明涉及一般式(I)的化合物，其中A-A为-CH2-CH2-，-CH2-CH2-CH2-，-CH2-0-或-0-CH2-；x为氢或羟基；R1为芳基或杂环芳基，未取代或由一个或多个取代基取代，所选取自较低烷基、较低烷氧基、卤素或三氟甲基的群组；R2为芳基或杂环芳基，未取代或由一个或多个取代基取代，所选取自较低烷基、较低烷氧基、卤素或三氟甲基的群组，或为较低烷基、-(CH2)n-环烷基、-(CH2)n-CF3、-(CH2)p-0-较低烷基、-(CH2)1,2-苯基，或者可由卤素、较低烷基、较低烷氧基或三氟甲基取代的苯基，或为-(CH2)p-NRR'，其中W和R'与N原子一起形成选自哌啶、吗啉、硫代吗啉或1,1-二氧硫代吗啉的杂环环的环；R3、R4相互独立为氢、较低烷基、苯基或苄基；R5为氢、较低烷基或苄基；R6为氢或较低烷基；n为0、1或2；p为2或3；以及其药用可接受的酸盐，用于治疗精神病、疼痛、记忆和学习中的神经退行性功能障碍、精神分裂症、痴呆症和其他认知过程受损的疾病，如注意力缺陷障碍或阿尔茨海默病。